60 degrees pharmaceuticals, Inc.(SXTP)
3.47+0.25+7.76%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称60 degrees pharmaceuticals, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况60 Degrees Pharmaceuticals, Inc.是特拉华州的一家公司，成立于2022年6月1日。该公司是一家专业制药公司，目标是利用前沿的生物科学和应用研究，进一步开发和商业化用于预防和治疗传染病的新疗法。该公司已成功获得监管机构对Arakoda的批准，这是一种自2019年底开始上市的疟疾预防疗法。目前，60P的在研管线涵盖了利用该公司未来的三种产品的病媒传播、真菌和病毒性疾病的开发计划。- 02-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-23Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-10-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-09Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-07-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-07-11Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-07-11Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-07-07Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-05-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-04-09Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
3.55
今开
3.17
量比
3.85
最低
2.93
昨收
3.22
换手率
159.21%